Orient Europharma Co Ltd

Orient Europharma's capital structure shows a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. The company's liquidity position is characterized by a current ratio of 1.47, suggesting it can cover its short-term obligations, but its operating cash flow is negative at -292.21 million TWD, and free cash flow is also negative at -480.05 million TWD. The company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics are weak, with a return on equity of -9.02% and a return on assets of -4.65%, both significantly below the industry median for pharmaceutical and food processing firms. The company reported a net loss of 567.39 million TWD and an operating loss of 318.91 million TWD, indicating operational inefficiencies and cost overruns. The company's revenue is concentrated in two primary segments: nutritious healthcare and medical cosmetic products, and western drugs. The western drugs segment includes products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases, and asthma. The nutritious healthcare segment includes infant milk powders, nutritious products, and functional healthcare products. The geographic exposure is not disclosed, but the company's operations are likely concentrated in its domestic market. Growth trajectory is negative, with the company reporting a net loss and negative operating cash flow. The outlook for the current fiscal year is not provided, but the company's recent performance suggests a challenging operating environment. The capital expenditure of -188.64 million TWD indicates a reduction in investment, which may signal a strategic shift or financial constraints. The company's risk assessment highlights medium liquidity risk and low dilution risk. The key flag of negative net cash after total debt suggests potential refinancing needs. The dilution risk is low, with no significant dilution sources identified in the latest filings. The company's financial performance and liquidity position may require close monitoring for potential refinancing or operational restructuring. Recent events include the company's financial performance as disclosed in the latest financial snapshot. The company's operating cash flow and free cash flow are negative, and it reported a net loss. No recent filings or transcripts are provided, but the financial snapshot indicates a challenging operating environment.